Clinical Trials on Stem Cells in Canada

Total 2456 results

Henrique Bittencourt, MD, PhD
Michel Duval, MD; Pierre Teira, MD; Sonia Cellot, MD, PhD; Isabelle Louis, PhD; Elie... and other collaborators

Completed

Intrabone Infusion of Umbilical Cord Blood Stem Cells

Hematopoietic Stem Cell Transplantation

Canada
Alberta Health services

Completed

ACB A Randomized Study of 2.5ug/kg/Day vs. 5ug/kg/Day Dose of G-CSF After High Dose Chemotherapy Followed by Autologous Peripheral Blood Stem Cell/Marrow Transplant Recipients FILE#17159

Peripheral Stem Cell/Marrow Transplant

Canada
CHU de Quebec-Universite Laval

Recruiting

Autologous Cultured Corneal Epithelium (CECA) for the Treatment of Limbal Stem Cell Deficiency (CECA)

Limbal Stem Cell Deficiency

Canada
St. Jude Children's Research Hospital

Completed

Testing the Effectiveness of Child and Parent-Targeted Health Promotion Interventions in Pediatric Stem Cell Transplantation

Stem Cell Transplant | Bone Marrow

United States, Canada
AHS Cancer Control Alberta

Not yet recruiting

Loratadine for the Prevention of G-CSF-related Bone Pain

Stem Cell Transplant Complications

Canada
University of Calgary
Alberta Children's Hospital

Terminated

Exercise in Pediatric Autologous Stem Cell Transplant Patients (SCORE)

Cancer | Autologous Hematopoietic Stem Cell Transplantation

Canada
AHS Cancer Control Alberta

Not yet recruiting

High Heated Humidity in Stem Cell Transplant

Autologous Stem Cell Transplant

Canada
University Health Network, Toronto
Toronto Rehabilitation Institute; Princess Margaret Hospital, Canada

Completed

Exercise Prior to Allogeneic Hematologic Stem Cell Transplantation

Allogeneic Stem Cell Transplantation

Canada
University Hospital, Geneva
European Society for Blood and Marrow Transplantation

Recruiting

Polymorphisms and Busulfan Pharmacokinetic Study

Children Who Receive a Stem Cell Transplantation With Busulfan IV

Canada, France, Switzerland
Unity Health Toronto
University of Western Ontario, Canada; Humber River Hospital

Completed

Effect of Weight Loss Surgery on Stem Cells.

Obesity, Morbid | Cardiovascular Morbidity | Stem Cells

Canada
Fundación Pública Andaluza para la gestión de la...

Completed

Immunomodulatory Effect of Vitamin D in Allogenic Post-transplant (Alovita-1)

Hematopoietic Stem Cell Transplantation

Spain
Marie Hudson, MD
Assistance Publique - Hôpitaux de Paris; Medical University of South Carolina; Centre hospitalier de l'Université de Montréal (CHUM) and other collaborators

Recruiting

Treatment With Human Umbilical Cord-derived Mesenchymal Stromal Cells in Systemic Sclerosis (CARE-SSc)

Mesenchymal Stem Cells | Sclerosis, Systemic

Canada
University of Calgary

Recruiting

Nonmyeloablative Stem Cell Transplant in Children With Sickle Cell Disease and a Major ABO-Incompatible Matched Sibling Donor (Sickle-AID)

Sickle Cell Disease | Pure Red Cell Aplasia | Stem Cell Transplant Complications | Red Blood Cell Disorder

Canada
Stephen Couban
Genzyme, a Sanofi Company

Completed

Healthy Donor Study II - Comparing Plerixafor With G-CSF and Plerixafor

Malignant Lymphoma, Stem Cell Type

Canada
Mount Sinai Hospital, Canada
Princess Margaret Hospital, Canada

Active, not recruiting

Low-Flow vs. High-Flow Nasal Cannula for Hypoxemic Immunocompromised Patients During Diagnostic Bronchoscopy

Hypoxia | Hematologic Malignancy | Immunocompromised | Post Hematopoietic Stem Cell Transplant | Pulmonary Infiltrates

Canada
Mount Sinai Hospital, Canada

Active, not recruiting

Critical Care Outcomes of Hematologic Oncology Patients (COHO)

Stem Cell Transplant | Hematologic Malignancy

Canada
Weill Medical College of Cornell University
National Cancer Institute (NCI)

Recruiting

Delirium in Children Undergoing Stem Cell Transplantation

Delirium | Stem Cell Transplant Complications

United States, Canada
Alberta Health Services, Calgary
Alberta Cancer Foundation; University of Victoria

Recruiting

Early Integration of Palliative and Supportive Care in Cellular Therapy (PALS_CT)

Lymphoma | Leukemia | Multiple Myeloma | Blood Cancer | Stem Cell Transplant Complications | Chimeric Antigen Receptor T-cell Therapy

Canada
University of British Columbia
Amgen

Terminated

Blinatumomab for MRD in Pre-B ALL Patients Following Stem Cell Transplant (OZM-097)

Minimal Residual Disease | B-cell Adult Acute Lymphoblastic Leukemia | Stem Cell Leukemia

Canada
Millennium Pharmaceuticals, Inc.

Completed

Vedolizumab in the Prophylaxis of Intestinal Acute Graft Versus Host Disease (aGVHD) in Participants Undergoing Allogeneic Hematopoietic Stem Cell (Allo-HSCT) Transplantation

Hematopoietic Stem Cells

United States, Spain, Taiwan, Australia, Canada, Singapore, Korea, Republic of, Mexico, Switzerland, Japan, Germany, Norway, Israel, Russian Federation, Hungary, United Kingdom, Italy, Romania, Brazil, France, Austria, Belgium, Port... and more
Lawson Health Research Institute
Hamilton Health Sciences Corporation; London Health Sciences Centre

Completed

Prospective Validation of Circulating Tumor Cells & Circulating Endothelial Cells as Biomarkers in Renal Cancer

Clear Cell Renal Cancer | Circulating Tumor Cells | Predictive Biomarkers | Prognostic Biomarkers | Circulating Endothelial Cells

Canada
PETHEMA Foundation

Completed

Meropenem Versus Meropenem Plus Glycopeptide in Patients With Febrile Neutropenia After Allogenic Blood Stem Cell Transplantation (MERONEM)

Febrile Neutropenia | Allogenic Blood Stem Cell Transplantation

Spain
National Cancer Institute (NCI)

Terminated

RO4929097 in Treating Patients With Recurrent Invasive Gliomas

Adult Anaplastic Oligodendroglioma | Adult Giant Cell Glioblastoma | Adult Glioblastoma | Adult Gliosarcoma | Adult Mixed Glioma | Recurrent Adult Brain Tumor | Adult Brain Stem Glioma

Canada
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Cord Blood Transplantation for Sickle Cell Anemia and Thalassemia

Hematologic Diseases | Anemia, Sickle Cell | Beta-Thalassemia | Hematopoietic Stem Cell Transplantation

United States, Canada
Laval University
Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie...

Not yet recruiting

Sequence of Vessel Interruption and Circulating Tumor Cells in Surgical Lung Cancer (CTC-01)

Lung Cancer | Surgery | Circulating Tumor Cell

Canada
PETHEMA Foundation
Janssen, LP; Adknoma Health Research

Recruiting

Evaluation of Maintenance With Bortezomib Plus Daratumumab (V-Dara) After Induction With Bortezomib, Melphalan, Prednisone Plus Daratumumab (VMP-Dara) in Newly Diagnosed Multiple Myeloma (MM) Patients Non-eligible for autoSCT

Multiple Myeloma | Non-eligible for Autologous Stem Cell Transplantation (ASCT)

Spain
University of Alberta

Completed

A Pilot Randomized Controlled Trial of Intravenous N-acetyl Cysteine in STEMI (PANACEA)

STEMI

Canada
Hamilton Health Sciences Corporation

Completed

Delayed Educational Reminders in Acute Myocardial Infarction (MI) (DERLA-STEMI)

Acute Myocardial Infarction | STEMI

Canada
Ottawa Heart Institute Research Corporation
Spartan Bioscience Inc.

Completed

Pharmacogenetic Approach to Anti-platelet Therapy for the Treatment of ST-segment Elevation Myocardial Infarction (STEMI) (RAPID STEMI)

STEMI

Canada
University of Manitoba
University of British Columbia; University of Toronto; Scripps Health; Sharp HealthCare

Recruiting

ST Elevation Myocardial Infarction Hemodynamic OutComes: Role of Non-Invasive Cardiac System (SHOCk-NICaS) Study (SHOCk-NICaS)

ST Elevation Myocardial Infarction (STEMI) Patients

Canada
British Columbia Cancer Agency
University of British Columbia; University of Utah; Pathway Genomics; Boreal Genomics

Completed

Cancer DNA Screening Pilot Study (CANDACE) (CANDACE)

Circulating Tumor Cells

Canada
CIBA VISION
University of Waterloo

Completed

Study of the Cell Response in the Tear Film After Overnight Contact Lens Wear (CORNWALL)

White Blood Cells

Canada
Memorial Sloan Kettering Cancer Center
Johns Hopkins University; M.D. Anderson Cancer Center; University of Colorado... and other collaborators

Completed

External Beam Radiation Therapy and Cetuximab Followed by Irinotecan and Cetuximab for Children and Young Adults With Newly Diagnosed Diffuse Pontine Tumors and High-Grade Astrocytomas

Brain Cancer

United States, Canada
Mead Johnson Nutrition
University of Alberta

Completed

Assessment of Fatty Acids in Infants' Blood Cells When Consuming Infant Formula Containing Long-Chain Polyunsaturated Fatty Acids

Levels of Fatty Acids in the Blood Cells of Infants

Canada
Takeda

Active, not recruiting

A Study of Oral Ixazomib Citrate (MLN9708) Maintenance Therapy in Participants With Multiple Myeloma Following Autologous Stem Cell Transplant

Multiple Myeloma | Autologous Stem Cell Transplant

United States, Spain, Australia, Czechia, Hungary, Taiwan, Italy, Denmark, Portugal, Singapore, Israel, Canada, France, Belgium, United Kingdom, Germany, Japan, Austria, Netherlands, Korea, Republic of, Poland, Greece, Colombia, Sweden, South Africa and more
University Health Network, Toronto
AstraZeneca; Mirati Therapeutics Inc.

Withdrawn

Pre-operative Mocetinostat (MGCD0103) and Durvalumab (MEDI4736) (PRIMED) for Squamous Cell Carcinoma of the Oral Cavity (PRIMED-001)

Squamous Cell Carcinoma, Head And Neck | Squamous Cell Carcinoma Mouth | Resectable Squamous Cell Carcinoma of Oral Cavity

Canada
National Cancer Institute (NCI)

Completed

Sunitinib in Treating Patients With Relapsed or Refractory Diffuse or Mediastinal Large B-Cell Lymphoma

Recurrent Adult Diffuse Large Cell Lymphoma | Stage IV Adult Diffuse Large Cell Lymphoma | Adult Diffuse Large Cell Lymphoma

Canada
National Cancer Institute (NCI)

Completed

Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors

Stage IIIA Non-Small Cell Lung Cancer | Stage IIIB Non-Small Cell Lung Cancer | Recurrent Ovarian Carcinoma | Stage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Recurrent Renal Cell Carcinoma | Stage III Renal Cell Cancer | Stage IV Skin Melanoma | Recurrent Non-Small Cell... and other conditions

Canada
University Health Network, Toronto
NuBiyota

Active, not recruiting

Role of Microbiome as a Biomarkers in Locoregionally-Advanced Oropharyngeal Squamous Cell Carcinoma 2 (ROMA LA-OPSCC2)

Head and Neck Squamous Cell Carcinoma

Canada
University Health Network, Toronto

Completed

Role of Microbiome as a Biomarkers in Locoregionally-Advanced Oropharyngeal Squamous Cell Carcinoma (ROMA LA-OPSCC)

Locoregionally-advanced Oropharyngeal Squamous Cell Carcinoma

Canada
University Health Network, Toronto

Completed

The Utility of Circulating Tumour Cells and Plasma microRNA in Esophageal Adenocarcinoma

Esophageal Cancer

Canada
Lawson Health Research Institute

Active, not recruiting

A Window of Opportunity Study to Assess the Modulation of Biomarkers in Head and Neck Squamous Cell Cancer (HNSCC) By Preoperative Treatment With BYL719

Head and Neck Squamous Cell Cancer

Canada
University Health Network, Toronto

Completed

Transoral Robotic Surgery and Tailored Radiotherapy in Unknown Primary and Small Squamous Cell Head and Neck Cancer (FIND)

Head and Neck Squamous Cell Carcinoma

Canada
AHS Cancer Control Alberta
University of Calgary; Calgary Health Region

Completed

PET-CT for Squamous Cell Carcinoma (SCC) of the Neck Nodes Unknown Primary Malignancy

Squamous Cell Cancer

Canada
University Health Network, Toronto

Completed

Biofeedback Rehabilitation to Improve Speaking and Eating in Public (Biofeedback)

Oral Cavity Squamous Cell Carcinoma

Canada
Lawson Health Research Institute

Recruiting

Hydrogen Peroxide Trial to Investigate the Efficacy of 30%H2O2 as a Topical Application Before Definitive Treatment

Basal Cell Carcinoma | Squamous Cell Carcinoma of Skin Differentiated

Canada
Ivan Litvinov

Terminated

Imvamune Vaccine for the Treatment of Non-melanoma Skin Cancer (MUSIC-01)

Basal Cell Carcinoma | Squamous Cell Carcinoma | Non-melanoma Skin Cancer

Canada
Nationwide Children's Hospital

Recruiting

A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion

High Grade Glioma | Diffuse Intrinsic Pontine Glioma

United States, Australia, Canada, Germany
University Health Network, Toronto
Mirati Therapeutics Inc.

Completed

Sitravatinib (MGCD516) and Nivolumab in Oral Cavity Cancer Window Opportunity Study (SNOW)

Squamous Cell Carcinoma of the Oral Cavity | Squamous Cell Carcinoma, Head And Neck | Squamous Cell Carcinoma Mouth

Canada
University Health Network, Toronto

Recruiting

Head and Neck Squamous Cell Carcinoma (HNSCC)PET-CT Pilot Study

Head and Neck Squamous Cell Carcinoma

Canada

Clinical Trials on Stem Cells in Canada

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Armenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations